Corrections Webinar Series

Date: December 3 and December 10, 2020
Time: 1:00 - 2:30 pm ET

COURSE DESCRIPTION & OVERALL GOAL
This webinar series will highlight strategies and approaches for the prevention and control of TB in correctional settings. Through review of current guidance and sharing of best practices, participants will recognize and discuss challenges along with triumphs when working with security and medical staff in corrections. The first webinar will focus on the screening, testing, and treatment recommendations for correctional settings and the second webinar will emphasize the importance of release planning and collaboration to ensure continuity of TB care in and out of correctional facilities.

Thursday, December 10, 2020
1:00 - 2:30 PM Eastern Time - Release Plan for Corrections: Best Practices and Strategies for Change

Ending Tuberculosis: Updates on Latent Tuberculosis Infection Testing and Treatment for Correctional Settings aired on Thursday, December 3, 2020 - Stay Tuned for the Webinar Archive!

WHO SHOULD ATTEND
This webinar is open to physicians, nurses, public health staff, other health care workers, and security staff who are involved in the prevention and care of TB in correctional settings.

WHY COURSE IS NEEDED
Correctional facilities are congregate settings with a high risk for TB transmission. TB education is important for correctional healthcare personnel to develop and enhance skills for testing and management of TB in these types of settings to improve adherence to current recommendations and overall outcomes. Release planning for inmates with active TB is a critical component of TB control and ensuring connection to care in the community. This educational activity will assist TB programs with incorporating patient-centered TB case management in correctional settings.

OBJECTIVES
Upon completion of these webinars, participants should be better able to:
• List two differences between latent tuberculosis infection (LTBI) and active tuberculosis (TB) disease.
• Identify the pros and cons of the tuberculin skin test (TST) and interferon gamma release assays (IGRA) for LTBI testing in correctional settings.
• Discuss updated LTBI treatment guidelines and their feasibility in correctional settings.
• Identify the roles that corrections security and medical staff, and public health staff play in release planning for active and high-priority TB infected patients to ensure continuity of care upon release to the community.
• Illustrate two steps for inmates being released to the community to assure positive outcomes and minimal transmission to others for active TB patients.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the webinar and complete an evaluation. Credit can be claimed for each individual session and attendance is not required for both sessions to claim credit.

CONTINUING EDUCATION INFORMATION

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences, Southeastern National TB Center, and National Tuberculosis Controllers Association. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates each live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: Each activity is awarded 1.5 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
There is no fee for this course. Participants need to register separately for the two webinars:

Register here.

We reserve the right to close registration early or cancel registrants due to limits on capacity.

CANCELLATION INFORMATION
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.

FUNDING DISCLOSURE
Funding for this conference was made possible by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Rosie Garcia at rg981@njms.rutgers.edu